MedTrace Logo

Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma

NCT06560255 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 2000

Last updated 2025-09-30

No results posted yet for this study

Summary

The overall aim of the study is to develop a nutritional preventive fish oil supplementation strategy in pregnancy for early childhood asthma/persistent wheeze during the first three years of life as we hypothesize that both supplementations in higher doses than recommended could reduce the risk of disease development.

Conditions

  • Asthma
  • Respiratory Tract Infections
  • Gastrointestinal Infection
  • Croup
  • Eczema
  • Allergy
  • Wheezing
  • Fractures, Bone
  • Development, Child
  • Cognition Disorders in Children
  • Psychiatric Diagnosis

Interventions

DIETARY_SUPPLEMENT

n-3 fatty acid

Oral intake of 4 capsules per day from week 22-26 in pregnancy to 1 week after delivery

OTHER

Rape seed oil

Oral intake of 4 capsules per day from week 22-26 in pregnancy to 1 week after delivery

Sponsors & Collaborators

  • Professor Klaus Bønnelykke

    lead OTHER

Principal Investigators

  • Bo Chawes, PhD · Copenhagen Studies on Asthma in Childhood

  • Klaus Bønnelykke, PhD · Copenhagen Studies on Asthma in Childhood

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-20
Primary Completion
2026-10-31
Completion
2033-03-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06560255 on ClinicalTrials.gov